Association between AKI and Long-Term Renal and Cardiovascular Outcomes in United States Veterans
AKI is associated with major adverse kidney events (MAKE): death, new dialysis, and worsened renal function. CKD (arising from worsened renal function) is associated with a higher risk of major adverse cardiac events (MACE): myocardial infarction (MI), stroke, and heart failure.
Restoration of the Coagulation Cascade on CPB: A Case Report
Coagulopathy can sometimes be observed when CPB times are prolonged.
Hot Shot Induction and Reperfusion with a Specific Blocker of the es-ENT1 Nucleoside Transporter Before and after Hypothermic Cardioplegia Abolishes Myocardial Stunning in Acutely Ischemic Hearts Despite Metabolic Derangement
Inhibition of cardiac es-ENT1 nucleoside transporter abolishes postischemic reperfusion injury in warm and cold cardiac surgery.
Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel Meeting on the Reclassification of External Counterpulsation, Intra-Aortic Balloon Pump, and Non-Roller-Type Cardiopulmonary Bypass Blood Pump Devices
The Food and Drug Administration held a Circulatory System Devices Advisory Panel meeting,
Unexpected Abrupt Increase in Left Ventricular Assist Device Thrombosis
We investigated the occurrence of pump thrombosis and elevated lactate dehydrogenase (LDH) levels, LDH levels presaging thrombosis (and associated hemolysis), and outcomes of different management strategies in a multi-institutional study.
Cardioprotection with Esmolol Cardioplegia: Efficacy as a Blood-Based Solution
An esmolol-based cardioplegic solution may be a beneficial alternative to hyperkalaemic solutions.